Boston Scientific :: Home. Zacks Analyst Blog Highlights: AstraZeneca, Pfizer, Mylan Labora. CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: AstraZeneca (NYSE: AZN), Pfizer (NYSE: PFE), Mylan Laboratories (Nasdaq: MYL), Novartis (NYSE: NVS) and Boston Scientific Corp. (NYSE: BSX). Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: Here are highlights from Monday’s Analyst Blog: FDA Backs Crestor’s Wider Use AstraZeneca (NYSE: AZN) received a positive opinion from the US Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) regarding the expanded use of Crestor.
Following the recommendation, AstraZeneca has moved one step closer to FDA approval. Crestor is one of AstraZeneca’s key drugs logging sales of about $3.6 billion last year. About Zacks. Boston Scientific Announces Retirement of Jim Tobin and Appointm. NATICK, Mass., June 25 / PRNewswire-FirstCall / -- Boston Scientific Corporation (NYSE: BSX) announced today that President and Chief Executive Officer (CEO) Jim Tobin will retire from the Company, and that its board of directors has appointed Ray Elliott the new President and CEO, effective July 13. (Photo: ) "Ten years ago this month, I began my tenure as CEO of Boston Scientific, and two months from now, I will turn 65," said Tobin.
"Over the course of the past decade, we have built a stronger, more diversified company that is well positioned for the future. We have achieved this due largely to the support of our employees, customers and investors, and I would like to take this opportunity to thank them. Now is an appropriate time for me to turn over the leadership of the Company to Ray Elliott, our new CEO. Ray is an outstanding choice, and he has my full and enthusiastic support. Mr. Boston Scientific Chooses Ray Elliott as Chief Executive - NYTim. The five biggest local stories of 2009. Thread Begining of the end of Boston Scientific CRM | Cafepharma. Top Leadership Terminated???? - Cafepharma Message Boards.
Boston Scientific :: IC :: Homepage. The Stentplus™ Patient Success Program Health Care Professionals. Site Map. About Coronary Stents.